EP2367553
COMBINATION THERAPY TO ENHANCE NK CELL MEDIATED CYTOTOXICITY
:
EP einkaleyfi: Þýðing ekki lögð inn:
4.12.2009:
3.5.2017:
09771629.4
:
3.12.2029
:
COMBINATION THERAPY TO ENHANCE NK CELL MEDIATED CYTOTOXICITY
4.12.2009
3.5.2017
:
Novo Nordisk A/S:
Novo Allé, 2880, Bagsværd, DK
:
FARAG, Sherif, S.:
CarmelIN, US
:
120242 P:
5.12.2008:
US
:
US2009066894:
4.12.2009
:
A61K 31/4439, A61K 39/395, A61P 35/00